| Application no. and date | 14805743.3 (espacenet) (Federated) (European Patent Register), 20141111 | | Patent/reg. no. and date | DK/EP 3068393, 20220309 | | Publication date | 20160921 | | Priority no. and date | US 201361902717 P, 20131111 | | EP pub. no. and date |
EP 3068393 20160921 | | Effective date | | | Applicant/owner | Amgen Inc., One Amgen Center Drive
Thousand Oaks, California 91320-1799, US | | Applicant ref. no. | P80045DK01 | | Inventor | HUGHES, Paul, 909 14th Street 1
Santa Monica, California 90403, US,
RICKLES, Richard J., 10 Knowles Farm Road
Arlington, Massachusetts 02474, US,
SAIKI, Anne Y., 4473 Cedarglen Court
Moorpark, California 93021, US,
CAENEPEEL, Sean, 2090 Stonehill Circle
Thousand Oaks, CA 91360, US,
CANON, Jude, 13240 Fiji Way, Unit A
Marina Del Rey, California 90292, US,
OLINER, Jonathan D., P.O Box 55
Garrett Park, MD 20896, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/451 (2006.01) , A61K 31/706 (2006.01) , A61K 31/7068 (2006.01) , A61P 35/02 (2006.01) | | Title | KOMBINATIONSTERAPI SOM INKLUDERER EN MDM2-INHIBITOR OG ET ELLER FLERE YDERLIGERE FARMACEUTISK AKTIVE MIDLER TIL BEHANDLINGEN AF KRÆFTFORMER | | Int. application no. | US2014065034 | | Int. publication no. | WO2015070224 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
